Related Experiment Video
Updated: Jan 22, 2026
Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies
Published on: February 9, 2024
The Prevalence of Chronic Opioid Use in Patients With Inflammatory Bowel Disease: A Nationwide Danish Register-Based
Jennifer Youn1, Jan Nielsen2,3, Erantis Sørensen2,3
1Department of Medicine, Tufts Medical Center, Boston, MA, United States.
Background:
Despite the common use of opioids in patients with inflammatory bowel disease (IBD), there are limited studies on the prevalence of chronic opioid use in this population.
Methods:
We conducted a nationwide Danish register-based study to examine the prevalence proportion of chronic opioid use in patients with IBD from 1996 to 2021. Analysis was performed for patients with Crohn's disease (CD) and ulcerative colitis (UC) and stratified by sex and age groups of young adults (18-39 years), adults (40-59 years), and elderly (+60 years).
Results:
A total of 51 837 patients with IBD were identified. The prevalence proportion of chronic opioid use increased from 1996 and reached the highest point at 14.26% (95% confidence interval [CI], 13.67%-14.84%) for patients with CD in 2011 and 8.21% (95% CI, 7.88%-8.54%) in patients with UC in 2012. Subsequently, the prevalence proportion of chronic opioid use decreased to 8.88% (95% CI, 8.41%-9.35%) in patients with CD and 4.96% (95% CI, 4.70%-5.21%) in patients with UC by 2021. Throughout the 25-year period, female patients had higher prevalence proportion of chronic opioid use compared with that of male patients. Elderly patients had higher prevalence proportion of chronic opioid use compared with that of adult and young adult patients.
Discussions:
Many patients with IBD rely on chronic opioid use as part of their pain management. Further investigations are needed to study the complications and sequelae of chronic opioid use in patients with IBD.
More Related Videos
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...